4 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
to attract and retain talent and encourage employees to innovate in its genetically defined disease business because equity performance will be more aligned
PREM14A
AGIO
Agios Pharmaceuticals Inc
29 Jan 21
Preliminary proxy related to merger
4:22pm
and encourage employees to innovate in its genetically defined disease business because equity performance will be more aligned with that business
- Prev
- 1
- Next